Trial Profile
A Single-Centre, Prospective, Observational Cohort Study Evaluating the Effectiveness and Safety of Ledipasvir/Sofosbuvir (LDV/SOF) in Real-World Patients with Chronic Hepatitis C Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Mar 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 06 Mar 2018 New trial record